Browse by author
Lookup NU author(s): Dean Ranasinghe, Professor James AllanORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Somatic mutations increasing hematopoietic stem cell (HSC) fitness drive their expansion in clonal hematopoiesis (CH) and predispose to blood cancers. Population variation in the growth rate and potential of mutant clones suggests genetic factors may confer resilience against CH. Here, we identified a non-coding regulatory variant, rs17834140-T, that protects against CH and myeloid malignancies by selectively downregulating the RNA-binding protein MSI2 in HSCs. By modeling variant effects and mapping MSI2 binding targets, we uncovered an RNA network that maintains human HSCs and influences CH risk. rs17834140-T was associated with slower CH expansion, and stem cell MSI2 levels modified ASXL1-mutant HSC clonal dominance. These findings leverage natural resilience to illuminate post-transcriptional regulation in human HSCs, suggesting inhibition of MSI2 or its targets for blood cancer prevention.
Author(s): Agarwal G, Antoszewski M, Xie X, Pershad Y, Arora UP, Poon C-L, Lyu P, Lee AJ, Guo C-J, Ye T, Norford LB, Neehus A-L, della Volpe L, Wahlster L, Ranasinghe D, Ho T-C, Barlowe T-S, Chow A, Schurer A, Taggart J, Durham BH, Abdel-Wahab O, McGraw KL, Allan JM, Soldatov R, Bick AG, Kharas MG, Sankaran VG
Publication type: Article
Publication status: In Press
Journal: Science
Year: 2025
Acceptance date: 27/10/2025
ISSN (print): 0036-8075
ISSN (electronic): 1095-9203
Publisher: American Association for the Advancement of Science
